MORANO, FRANCESCO Statistiche
MORANO, FRANCESCO
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study
2021-01-01 Raimondi, A.; Fuca, G.; Leone, A. G.; Lonardi, S.; Antoniotti, C.; Smiroldo, V.; Amatu, A.; Tampellini, M.; Ritorto, G.; Murialdo, R.; Clavarezza, M.; Zaniboni, A.; Berenato, R.; Ratti, M.; Corallo, S.; Morano, F.; Di Bartolomeo, M.; Di Maio, M.; Pietrantonio, F.
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
2021-01-01 Borelli, B.; Fontana, E.; Giordano, Mirella.; Antoniotti, Carlotta.; Lonardi, S.; Bergamo, F.; Pietrantonio, F.; Morano, F.; Tamburini, E.; Boccaccino, Alessandra.; Santini, D.; Zucchelli, G.; Pella, N.; Maiello, E.; Passardi, A.; Zaniboni, A.; Ugolini, C.; Fontanini, Gabriella.; Falcone, Alfredo.; Nyamundanda, G.; Sadanandam, A.; Cremolini, C.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study
2021-01-01 Manca, P.; Corallo, S.; Lonardi, S.; Fuca, G.; Busico, A.; Leone, A. G.; Corti, F.; Antoniotti, C.; Procaccio, L.; Smiroldo, V.; Ratti, M.; Murialdo, R.; Racca, P.; Pagani, F.; Randon, G.; Martinetti, A.; Sottotetti, E.; Prisciandaro, M.; Ambrosini, M.; Raimondi, A.; Morano, F.; Pietrantonio, F.
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected
2018-01-01 Pietrantonio, F; Di Nicolantonio, F; Schrock, A B; Lee, J; Morano, F; Fuca, G; Nikolinakos, P; Drilon, A; Hechtman, J F; Christiansen, J; Gowen, K; Frampton, G M; Gasparini, P; Rossini, D; Gigliotti, C; Kim, S T; Prisciandaro, M; Hodgson, J; Zaniboni, A; Chiu, V K; Milione, M; Patel, R; Miller, V; Bardelli, A; Novara, L; Wang, L; Pupa, S M; Sozzi, G; Ross, J; Di Bartolomeo, M; Bertotti, A; Ali, S; Trusolino, L; Falcone, A; de Braud, F; Cremolini, C
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation
2018-01-01 Morano, F; Corallo, S; Niger, M; Barault, L; Milione, M; Berenato, R; Moretto, R; Randon, G; Antista, M; Belfiore, A; Raimondi, A; Nichetti, F; Martinetti, A; Battaglia, L; Perrone, F; Pruneri, G; Falcone, A; Di Bartolomeo, M; de Braud, F; Di Nicolantonio, F; Cremolini, C; Pietrantonio, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study | 1-gen-2021 | Raimondi, A.; Fuca, G.; Leone, A. G.; Lonardi, S.; Antoniotti, C.; Smiroldo, V.; Amatu, A.; Tampellini, M.; Ritorto, G.; Murialdo, R.; Clavarezza, M.; Zaniboni, A.; Berenato, R.; Ratti, M.; Corallo, S.; Morano, F.; Di Bartolomeo, M.; Di Maio, M.; Pietrantonio, F. | |
| Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study | 1-gen-2021 | Borelli, B.; Fontana, E.; Giordano, Mirella.; Antoniotti, Carlotta.; Lonardi, S.; Bergamo, F.; Pietrantonio, F.; Morano, F.; Tamburini, E.; Boccaccino, Alessandra.; Santini, D.; Zucchelli, G.; Pella, N.; Maiello, E.; Passardi, A.; Zaniboni, A.; Ugolini, C.; Fontanini, Gabriella.; Falcone, Alfredo.; Nyamundanda, G.; Sadanandam, A.; Cremolini, C. | |
| Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study | 1-gen-2021 | Manca, P.; Corallo, S.; Lonardi, S.; Fuca, G.; Busico, A.; Leone, A. G.; Corti, F.; Antoniotti, C.; Procaccio, L.; Smiroldo, V.; Ratti, M.; Murialdo, R.; Racca, P.; Pagani, F.; Randon, G.; Martinetti, A.; Sottotetti, E.; Prisciandaro, M.; Ambrosini, M.; Raimondi, A.; Morano, F.; Pietrantonio, F. | |
| RET fusions in a small subset of advanced colorectal cancers at risk of being neglected | 1-gen-2018 | Pietrantonio, F; Di Nicolantonio, F; Schrock, A B; Lee, J; Morano, F; Fuca, G; Nikolinakos, P; Drilon, A; Hechtman, J F; Christiansen, J; Gowen, K; Frampton, G M; Gasparini, P; Rossini, D; Gigliotti, C; Kim, S T; Prisciandaro, M; Hodgson, J; Zaniboni, A; Chiu, V K; Milione, M; Patel, R; Miller, V; Bardelli, A; Novara, L; Wang, L; Pupa, S M; Sozzi, G; Ross, J; Di Bartolomeo, M; Bertotti, A; Ali, S; Trusolino, L; Falcone, A; de Braud, F; Cremolini, C | |
| Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation | 1-gen-2018 | Morano, F; Corallo, S; Niger, M; Barault, L; Milione, M; Berenato, R; Moretto, R; Randon, G; Antista, M; Belfiore, A; Raimondi, A; Nichetti, F; Martinetti, A; Battaglia, L; Perrone, F; Pruneri, G; Falcone, A; Di Bartolomeo, M; de Braud, F; Di Nicolantonio, F; Cremolini, C; Pietrantonio, F |